Journal article

Alternate-day, low-dose aspirin and cancer risk.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Rothwell, P. (2013). Alternate-day, low-dose aspirin and cancer risk. Annals of Internal Medicine, 159(2), 148–150.

MLA Style

Rothwell, P. “Alternate-Day, Low-Dose Aspirin and Cancer Risk.” Annals of Internal Medicine, vol. 159, no. 2, 2013, pp. 148–50.

Chicago Style

Rothwell, P. 2013. “Alternate-Day, Low-Dose Aspirin and Cancer Risk.” Annals of Internal Medicine 159 (2): 148–50.
Share
Print

Access Document

Publisher copy:: 10.7326/0003-4819-159-2-201307160-00013

Authors

+ Rothwell, P More by this author

Institution:: University of Oxford
Division:: MPLS
Department:: Engineering Science
Sub department:: Institute of Biomedical Engineering
Role:: Author

Journal:: Annals of internal medicine More from this journal
Volume:: 159
Issue:: 2
Pages:: 148-150
Publication date:: 2013-07-01
DOI:: 10.7326/0003-4819-159-2-201307160-00013
EISSN:: 1539-3704
ISSN:: 0003-4819

Language:: English
Keywords:: Platelet Aggregation Inhibitors

Female

Neoplasms

Aspirin

Humans
Pubs id:: pubs:415776
UUID:: uuid:796a5f3f-d31f-47e4-a87a-93607e3eb80b
Local pid:: pubs:415776
Source identifiers:: 415776
Deposit date:: 2013-11-17

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP